Company: CCHH
Filing Date: 2025-06-26
Form Type: DRS
Source: 0001213900-25-058036
Chunk: 34

Company: CCH Holdings Ltd
Filing Date: 2025-06-26
Form: DRS
Chunk 34
---
 our outstanding equity securities or sales of additional equity securities; and •potential litigation or regulatory investigations. Any of these factors may result in large and sudden changes in the volume and price at which our ordinary shares will trade. In the past, shareholders of public companies have often brought securities class action suits against companies following periods of instability in the market price of their securities. If we were involved in a class action suit, it could divert a significant amount of our management’s attention and other resources from our business and operations and require us to incur significant expenses to defend the suit, which could harm our results of operations. Any such class 22 action suit, whether or not successful, could harm our reputation and restrict our ability to raise capital in the future. In addition, if a claim is successfully made against us, we may be required to pay significant damages, which could have a material adverse effect on our financial condition and results of operations. We may not maintain the listing of our ordinary shares on Nasdaq, which could limit investors’ ability to make transactions in our ordinary shares and subject us to additional trading restrictions. We intend to list our ordinary shares on the Nasdaq concurrently with this offering. In order to continue listing our ordinary shares on Nasdaq, we must maintain certain financial and share price levels, and we may be unable to meet these requirements in the future. We cannot assure you that our ordinary shares will continue to be listed on Nasdaq in the future. If Nasdaq delists our ordinary shares and we are unable to list our ordinary shares on another national securities exchange, we will endeavor to have our ordinary shares quoted on an over -the -countermarket in the United States. If this were to occur, we could face significant material adverse consequences, including: •a limited availability of market quotations for our ordinary shares; •reduced liquidity for our ordinary shares; •a determination that our ordinary shares are a “penny stock,” which would require brokers trading in our shares to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our ordinary shares; •a limited amount of news and analyst coverage; and •a decreased ability to issue additional securities or obtain additional financing in the future. As long as our ordinary shares are listed on Nasdaq, U.S. federal law prevents or preempts states from regulating their sale of those listed ordinary shares. However, the law does permit states to investigate companies if there is a suspicion of fraud, and, if there is a finding of fraudulent activity, then